Testimonials

“We thoroughly enjoyed the eye-opening seminars. BioBusiness allows a more intimate, honest and constructive exhcange of opinions than other confernces.”

Rami Suzuki, Senior Manger, Oncology, Corporate Business Development Eisai

“The size and exclusivity of the audience at BioBusiness make it an exptremely productive Bio-partnering event.”

Margaret Beer, Scientific Liason, Merck

“A very successful event for me, both the informal and formal netowrking is outsanding.”

Christine Lemke, VP Business Development, Medigene

“I attend many confernces in my role at GSK, but I certainly foudn this event to be of very high quality and extremely useful."

Kate Burt, Director, Commercial Alliances and Transactions, Worldwide Busienss Development, GlaxoSmithKline

“This was a meeting of the right size and focus to put together industry representatives with common goals and to allow sufficient time and psace to have meaningful discussions. It was also well-coordinated.”

Kay Wagoner, CEO, Icagen

“BioBusiness is totally unique - a discreet, exclusive, yet relaxed environment for intiating and dveloping meaningful links with the right people.”

Hans Peter Hasler, Vice President International, Biogen Idec